Predicting Pain Exacerbations in Children With Complex Regional Pain Syndrome (CRPS)
Launched by STANFORD UNIVERSITY · Mar 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding what causes severe pain flare-ups in children with Complex Regional Pain Syndrome (CRPS). The researchers want to identify different factors that might trigger these pain episodes, such as physical changes in the body, what the children eat, and their surroundings. By learning more about these triggers, they hope to improve how we manage pain in children with CRPS.
The trial is open to children aged between 2 and 6 years old, and both boys and girls can participate. To be eligible, a child must have a clinical diagnosis of CRPS, which means they have been diagnosed by a healthcare professional. If you decide to participate, you can expect to provide information about your child’s health, diet, and environment. It’s important to know that the trial is not recruiting participants yet, so there will be more information available soon for those interested in joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of...
- Exclusion Criteria:
- • -
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
ANDREW DINH, MD
Principal Investigator
Stanford University
ELLIOT KRANE, MD
Study Director
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported